Research

ArthramidVet White Papers

2.5% IPAAG Clinical Studies

  • Animals
  • Humans
Tnibar et al. Acta Veterinaria Scandinavica (2015) An international multi-centre prospective study on the efficacy of an intraarticular polyacrylamide hydrogel in horses with osteoarthritis: a 24 months follow-up
Mechanisms of Action of an Intraarticular 2.5% Polyacrylamide Hydrogel (Arthramid Vet) in a Goat Model of Osteoarthritis: Preliminary Observations
Bath AP et al – IA Polyacrylamide in 20 horses – Prospective Study
Christensen et al – Synovial Incorporation of PAAG
de Clifford et al – Use of a 2.5 Cross Linked Polyacrylamide Hydrogel in the Flat Racing
Lowe – Histologic and Cytologic changes in normla equine joints after injection with 2.5% iPAAG
Tnibar Intra-articular 2.5% polyacrylamide hydrogel, a new concept in the medication of equine osteoarthritis: A review
TnibarA etal – Goat Model OA and MOA
M. Henriksen, A. Overgaard, A. Hartkopp, H.Bliddal Intra-articular 2.5% polyacrylamide hydrogel for the treatment of knee osteoarthritis: an observational proof-of-concept cohort study
Overgaard A, et al – Safety of Intra-Articular Polyacrylamide Hydrogel for the Treatment
of Knee Osteoarthritis Symptoms: A Retrospective Case Series
Biddal H. – Polyacrylamide Hydrogel Injection for Knee Osteoarthritis: A 6
Months Prospective Study of Knee Osteoarthritis Symptoms: A Retrospective Case Series
3 Year Results From A Prospective Study of Polyacrylamide Hydrogel for Knee Osteoarthritis